Heart EXPAND Continued Access Protocol
Purpose
The OCS™ Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.
Condition
- Heart Transplant
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Criteria
Inclusion Criteria (DONOR):
At least one of the following:
- Expected total cross-clamp time of ≥ 4 hours
- Expected total cross-clamp time of ≥ 2 hours PLUS one or more of the following risk
factors Donor age 45-55 years, inclusive, with no coronary catheterization data; or
Donor age ≥ 55 years; or Left ventricular septal or posterior wall thickness of >12
mm, but ≤ 16 mm; or Reported down time of ≥ 20 min, with stable hemodynamics at time
of final assessment; or Left heart ejection fraction (EF) ≥ 40%, but ≤ 50% at time of
acceptance of offer; or Donor angiogram with luminal irregularities with no
significant CAD (≤ 50%); or History of carbon monoxide poisoning with good cardiac
function at time of donor assessment; or Social history of alcoholism with good
cardiac function at time of donor assessment; or History of diabetes without
significant CAD (≤ 50%) on angiogram.
Exclusion
- CAD with > 50% stenosis on angiogram, or
- Cardiogenic shock or myocardial infarction, or
- EF consistently < 40%, or
- Significant valve disease except for competent bicuspid aortic valve.
Eligibility Criteria (RECIPIENT)
- Registered primary heart transplant candidate
- Age >18 years old
- Written informed consent. Exclusion
- Prior solid organ or bone marrow transplant
- Chronic use of hemodialysis or renal replacement therapy for diagnosis of chronic
renal insufficiency requiring dialysis
- Multi-organ transplant.
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental OCS Preservation |
|
More Details
- Status
- Completed
- Sponsor
- TransMedics
Study Contact
Detailed Description
To provide additional data evaluating the safety and effectiveness of the OCS™ Heart System to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria (as identified above) for transplantation to potentially improve donor heart utilization for transplantation at a range of transplant centers in the U.S. and to permit patients and physicians access to the OCS Heart System while a PMA application is under preparation and review.